Julio Castro-Palomino

Board member and co-founder

PhD in Chemistry from the University of Konstanz (Germany), with more than 20 years experience in the design of new drugs in the pharmaceutical and biotechnology industry (Bayer, Almirall, Oryzon). Julio is a serial entrepreneur, promoting the creation of 4 companies in the field of R&D of new drugs: Palobiofarma (of which he is CEO), Oncostellae, Medibiofarma and Origo Biopharma. Licensed out a project to Novartis from Palobiofarma.